Safety, tolerability, and efficacy of NLY01 in early untreated Parkinsons disease: a randomised, double-blind, placebo-controlled trial
The rationale is dual-pathway activation: CJC-1295 (GHRH analog) activates the GHRH receptor to stimulate GH synthesis and baseline release Ipamorelin (ghrelin mimetic) activates GHS-R1a to amplify GH pulse amplitude By engaging both regulatory pathways simultaneously, researchers have observed synergistic GH elevation greater than either compound alone
J., Thompson, W., Larsen, C
Efficacy and Safety of Oral Orforglipron in Patients With Type 2 Diabetes: A Multicentre, Randomised, Dose-Response, Phase 2 Study
It can help improve tolerance to treatments such as chemotherapy and radiation, reduce the risk of dehydration caused by prolonged vomiting, and improve overall quality of life during recovery